Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Glenisson Form 3/A Corrects ADS Title in Jumia Filing

Renaud Matthieu Glenisson, Regional CEO of Jumia Technologies AG, filed an amended initial statement of beneficial ownership (Form 3/A) on November 2, 2026, to correct a clerical error in the security title reported in the original Form 3 filed on October 29, 2026.

Manish Choudhary | 02 November 2026

Ryder CFO Gallo-Aquino Exercises and Sells 1,238 Shares

Cristina Gallo-Aquino, Executive Vice President and CFO of Ryder System Inc, filed a Form 4 on November 2, 2026, reporting the exercise of 1,238 stock options and the same-day sale of 1,238 shares of common stock on October 29, 2026.

Shwetambri Chauhan | 02 November 2026

Masaru Matsuda Files Form 144 for 1,219 Arcutis Shares

Arcutis Biotherapeutics, Inc. officer Masaru Matsuda filed a Form 144 notice of proposed sale of 1,219 shares of common stock on November 2, 2026, following a restricted stock vesting event on November 1, 2026.

Vinay Lochav | 02 November 2026

Wingstop Director McDonald Sells 1,520 Shares at $145.11

A Form 4 filed with the SEC on November 2, 2026, discloses that Wesley S. McDonald, a director of Wingstop Inc. (NASDAQ:WING), sold 1,520 shares of common stock on October 30, 2026, at a price of $145.11 per share.

Aakashdeep | 02 November 2026

Wingstop COO Raj Kapoor Sells 2,500 Shares at $163.61

Raj Kapoor, Senior Vice President and Chief Operating Officer of Wingstop Inc., filed a Form 4 on November 2, 2026, reporting the sale of 2,500 shares of Wingstop common stock on that same date.

Aakashdeep | 02 November 2026

Elliott Sells 16,882 JELD-WEN Shares for Tax Coverage

Rachael B. Elliott, EVP of North America at JELD-WEN Holding, Inc., filed a Form 4 on November 2, 2026, reporting the disposition of 16,882 shares of common stock to cover tax obligations tied to a restricted stock unit vesting.

Vinay Lochav | 02 November 2026

Sakhamuri Joins CRISPR Therapeutics as Chief Technical Officer

Sivakesava Sakhamuri filed a Form 3 initial statement of beneficial ownership with the SEC on November 2, 2026, disclosing his status as Chief Technical Officer of CRISPR Therapeutics AG (NASDAQ:CRSP) and reporting no securities beneficially owned.

Aakashdeep | 02 November 2026

Laura O'Shaughnessy Holds 12% of Graham Holdings Class B

Laura G. O'Shaughnessy filed an amended Schedule 13D with the Securities and Exchange Commission on November 2, 2026, disclosing her beneficial ownership of Class B Common Stock in Graham Holdings Company, a Delaware-incorporated media and education conglomerate headquartered in Arlington, Virginia.

Vinay Lochav | 02 November 2026

Exicure Seeks 400M Share Authorization at Dec 2026 Meeting

Exicure, Inc. filed a preliminary proxy statement on November 2, 2026, soliciting stockholder votes on six proposals at its 2026 Annual and Special Meeting of Stockholders scheduled for December 2, 2026.

Vinay Lochav | 02 November 2026

Arbiter Partners Discloses 5.2% Stake in Silver Bow Mining

Arbiter Partners Capital Management LLC and Paul J. Isaac filed a Schedule 13G with the SEC on November 2, 2026, disclosing beneficial ownership of 1,538,900 common shares of Silver Bow Mining Corp. as of October 27, 2026.

Nitish Kishor | 02 November 2026
Support

Hi! How can we help you today?

Loading…